These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3244183)

  • 1. [AG1749: a study of its inhibition of gastric pH after morning or evening dosage].
    Kihira K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2693. PubMed ID: 3244183
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H; Hokari K; Asaka M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO; Hatlebakk JG; Castell DO
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
    Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
    Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing.
    Hongo M; Ohara S; Hirasawa Y; Abe S; Asaki S; Toyota T
    Dig Dis Sci; 1992 Jun; 37(6):882-90. PubMed ID: 1534047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute treatment of duodenal ulcer: experience with lansoprazole.
    Mignon M; Vallot T
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():37-40, discussion 61-6. PubMed ID: 8490078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration.
    Chiverton SG; Howden CW; Burget DW; Hunt RH
    Aliment Pharmacol Ther; 1992 Feb; 6(1):103-11. PubMed ID: 1543812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lansoprazole on gastric ulcer healing and mucin content.
    Komuro Y; Ishii K; Miyake Y; Tanabe S; Oida M; Saigenji K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
    Brummer RJ; Geerling BJ; Stockbrügger RW
    Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF; Fraser R; Armstrong D; Blum AL
    Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Tazuma S; Horikawa Y; Nakamura M
    Dig Dis Sci; 2005 Jul; 50(7):1202-6. PubMed ID: 16047460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.
    Berlin I; Molinier P; Duchier A; Cournot A; Durrel J; Dellatolas F; Duchier J
    Eur J Clin Pharmacol; 1992; 43(2):117-9. PubMed ID: 1425865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helicobacter pylori infection on gastric juice pH.
    Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
    Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
    Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
    J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
    Ashida K; Sakaguchi M; Tanaka M; Takiuchi H; Egashira Y; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S67-71. PubMed ID: 7594345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.